14-day Premium Trial Subscription Sign Up For FreeGet Free

CTI BioPharma Corp. Stock Forecast NASDAQ:CTIC

Price Target and Analyst Ratings

Most Recent Rating

On August 31, 2021 "JMP Securities" gave "$4.00" rating for CTIC. The price target was set to $2.96+3.9%.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2021-08-31 $4.00 Reiterated by JMP Securities $3.02 $2.96+3.9%
2021-08-09 $7.00 Initiated by BTIG Research $2.98 $2.80+10.7%
2021-07-30 $4.00 Reiterated by JMP Securities $2.37 $2.39
2021-06-01 Buy Target Raised by Lake Street Capital $2.50 $13.00 → $15.00
2021-05-12 Buy Initiated by Stifel Nicolaus $2.21 $5.50
2021-05-06 Buy Initiated by Stifel Nicolaus $2.22 $5.50
2021-05-06 Buy Initiated by Stifel Nicolaus $2.22
2021-01-04 Buy Target Raised by Lake Street Capital $3.36 $8.00 → $13.00
2020-10-23 Buy Initiated by Brookline Capital Management $3.50 $7.00
2020-09-30 Buy Target Raised by Needham & Company LLC $2.15 $3.50 → $6.00
2020-07-05 Buy - Market Perform Reiterated by Lake Street Capital $1.18 $4.00
2020-06-24 Outperform Initiated by JMP Securities $1.21 $3.00

CTIC Stock Trend

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled.

Given the current short-term trend, the stock is expected to rise 34.67% during the next 3 months and, with a 90% probability hold a price between $3.79 and $4.37 at the end of this 3-month period.

Data

Date Bottom Mid Top
2021-09-20 $2.83 $3.04 $3.26
2021-09-21 $2.84 $3.06 $3.27
2021-09-22 $2.86 $3.07 $3.29
2021-09-23 $2.87 $3.08 $3.30
2021-09-24 $2.88 $3.10 $3.31
2021-09-27 $2.89 $3.11 $3.33
2021-09-28 $2.91 $3.12 $3.34
2021-09-29 $2.92 $3.14 $3.35
2021-09-30 $2.93 $3.15 $3.37
2021-10-01 $2.95 $3.16 $3.38
2021-10-04 $2.96 $3.18 $3.39
2021-10-05 $2.97 $3.19 $3.41
2021-10-06 $2.99 $3.20 $3.42
2021-10-07 $3.00 $3.22 $3.43
2021-10-08 $3.01 $3.23 $3.45
2021-10-11 $3.03 $3.24 $3.46
2021-10-12 $3.04 $3.26 $3.47
2021-10-13 $3.05 $3.27 $3.49
2021-10-14 $3.07 $3.28 $3.50
2021-10-15 $3.08 $3.30 $3.51
2021-10-18 $3.09 $3.31 $3.52
2021-10-19 $3.11 $3.32 $3.54
2021-10-20 $3.12 $3.34 $3.55
2021-10-21 $3.13 $3.35 $3.56
2021-10-22 $3.15 $3.36 $3.58
2021-10-25 $3.16 $3.38 $3.59
2021-10-26 $3.17 $3.39 $3.60
2021-10-27 $3.19 $3.40 $3.62
2021-10-28 $3.20 $3.42 $3.63
2021-10-29 $3.21 $3.43 $3.64

About CTI BioPharma Corp.

CTI BioPharma Corp., a biopharmaceutical company, engages in the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States and internationally. It primarily focuses on the commercialization of PIXUVRI, an aza-anthracenedione for the treatment of adult patients with multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma in the European Union. The company is also devel... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT